A Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)
NCT07794761
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
180
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
Berobenatide
OTHER:
Placebo
Sponsor
Pfizer